Drug-Drug Interaction Study To Evaluate The Effect Of Multiple Doses Of ISIS 681257 40 mg Subcutaneous Injections On The Pharmacokinetics And Pharmacodynamics Of Clopidogrel In Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Apr 2018
At a glance
- Drugs IONIS APOa-LRx (Primary) ; Clopidogrel
- Indications Hyperlipoproteinaemia
- Focus Pharmacokinetics
- Sponsors Akcea Therapeutics
- 03 Apr 2018 Status changed from active, no longer recruiting to completed.
- 19 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Jan 2018 New trial record